Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
working within Theme 3 of the Programme: ‘Image-guided Surgery’ and will involve the synthesis and assessment of novel multimodal nanomaterials for healthcare applications and radiolabel for PET imaging
-
and bioinformatics tools and methods. We are part of the School of Neuroscience within the Institute of Psychiatry, Psychology & Neuroscience (IoPPN). The IoPPN is a leading centre for mental health and
-
and regenerative medicine Team worker Desirable criteria Original research publications Presentation skills Knowledge of bioinformatics Please note that this is a PhD level role but candidates who have
-
Team worker Desirable criteria Home office personal licence Presentation skills Knowledge of bioinformatics We pride ourselves on being inclusive and welcoming. We embrace diversity and want everyone
-
with an excellent track record in bioscience education to deliver teaching in the areas of biomedical science with a particular emphasis on pharmacology, molecular genetics and/or bioinformatics. We
-
of neurodegeneration and accelerating the discovery, development and delivery of interventions that will help diagnose, treat and ultimately prevent dementia. Our laboratory-based research groups are located at King’s
-
to develop research profile, travel for conferences and presentations, as well as contribute to academic publications. The post holder is expected to hold a PhD degree in Bioinformatics, Computer Science
-
the “ground plan” of the brain is genetically determined, it is also influenced by environmental experience. We are still far from a complete understanding of how these processes work. CDN is one of four
-
experimental quality and reproducibility, coordinating sample acquisition from human islet biobanks and animal colonies, and integrating multi-modal datasets in collaboration with bioinformatics partners
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported